Mutations Outside the Ure2 Amyloid-Forming Region Disrupt [URE3] Prion Propagation and Alter Interactions with

Shailesh Kumar1, Elliot A Dine1, Ethan Paddock1

  • 1Laboratory of Biochemistry and Genetics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.

Insights

Altering yeast Ure2 protein outside its prion region can disrupt [URE3] prion propagation. These changes affect interactions with protein quality control factors, offering new strategies for prion curing.

Area of Science:

  • Molecular biology
  • Yeast genetics
  • Prion biology

Background:

  • Yeast prions, like [URE3] formed by Ure2 protein, propagate as amyloids.
  • Protein quality control (PQC) factors are essential for prion propagation and can be targeted for prion curing.
  • The precise interactions between PQC factors and prion proteins are not fully understood.

Purpose of the Study:

  • To investigate how mutations outside the Ure2 prion-determining region affect [URE3] prion stability and propagation.
  • To explore the role of non-amyloid forming regions of Ure2 in interactions with protein quality control factors.

Main Methods:

  • Generated and characterized mutations in the Ure2 protein outside its prion-forming region.
  • Assessed the impact of mutations on [URE3] prion loss, propagation, and sensitivity to PQC factors (Btn2, Cur1, Hsp42).
  • Evaluated in vitro amyloid formation and prion replication/transmission for specific mutants.

Main Results:

  • Most Ure2 mutants outside the prion region retained protein activity.
  • Four mutants rapidly lost [URE3] but could re-propagate it under selective conditions.
  • Mutations differentially affected sensitivity to specific PQC factors and in vitro amyloid formation, impacting prion replication or transmission.

Conclusions:

  • Dispersed sites outside the amyloid-forming region of Ure2 significantly influence prion character.
  • Modifying these sites can disrupt prion propagation by altering interactions with PQC systems.
  • This highlights potential new therapeutic targets for prion diseases by modulating protein interactions.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
11.4K
Amyloid Fibrils03:03

Amyloid Fibrils

6.2K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.0K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.8K
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.4K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
9.8K